155 related articles for article (PubMed ID: 32958737)
41. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
42. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
[TBL] [Abstract][Full Text] [Related]
43. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
44. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall.
Poulsen AL; Horn T; Steven K
J Urol; 1998 Dec; 160(6 Pt 1):2015-9; discussion 2020. PubMed ID: 9817313
[TBL] [Abstract][Full Text] [Related]
45. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer.
Stein JP; Penson DF; Cai J; Miranda G; Skinner EC; Dunn MA; Groshen S; Lieskovsky G; Skinner DG
J Urol; 2007 Mar; 177(3):876-81; discussion 881-2. PubMed ID: 17296365
[TBL] [Abstract][Full Text] [Related]
46. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
[TBL] [Abstract][Full Text] [Related]
47. [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
Hao H; Su XH; Zheng W; Ge P; He Q; Shen Q; Yang XY; Zhang Z; Li XS; Lin J; Zhou LQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):627-631. PubMed ID: 29263502
[TBL] [Abstract][Full Text] [Related]
48. Robot-assisted partial cystectomy for the treatment of urachal carcinoma.
Rabah DM
Can J Urol; 2007 Aug; 14(4):3640-2. PubMed ID: 17784985
[TBL] [Abstract][Full Text] [Related]
49. [Clinical significance of radical cystectomy with extended lymphadenectomy].
Liu XZ; Shen KH; Yan XD; Yu W; Guo YL; He Q; Xi ZJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):574-8. PubMed ID: 21844970
[TBL] [Abstract][Full Text] [Related]
50. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
Welty CJ; Sanford TH; Wright JL; Carroll PR; Cooperberg MR; Meng MV; Porten SP
Cancer; 2017 Dec; 123(23):4574-4582. PubMed ID: 28881475
[TBL] [Abstract][Full Text] [Related]
51. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
52. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results.
Lerner SP; Skinner DG; Lieskovsky G; Boyd SD; Groshen SL; Ziogas A; Skinner E; Nichols P; Hopwood B
J Urol; 1993 Apr; 149(4):758-64; discussion 764-5. PubMed ID: 8455238
[TBL] [Abstract][Full Text] [Related]
53. Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.
Retz M; Rotering J; Nawroth R; Buchner A; Stöckle M; Gschwend JE; Lehmann J
Eur Urol; 2011 Aug; 60(2):231-8. PubMed ID: 21190793
[TBL] [Abstract][Full Text] [Related]
54. A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density.
Cheng CW; Ng CF; Chan CK; Wong WS; Hui PE; Wong YF
Int Braz J Urol; 2006; 32(5):536-49. PubMed ID: 17081322
[TBL] [Abstract][Full Text] [Related]
55. Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis.
Matsumoto R; Takada N; Abe T; Minami K; Harabayashi T; Nagamori S; Hatanaka KC; Miyajima N; Tsuchiya K; Maruyama S; Murai S; Shinohara N
Jpn J Clin Oncol; 2015 Sep; 45(9):874-80. PubMed ID: 26109677
[TBL] [Abstract][Full Text] [Related]
56. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
Collins JW; Tyritzis S; Nyberg T; Schumacher M; Laurin O; Khazaeli D; Adding C; Jonsson MN; Hosseini A; Wiklund NP
Eur Urol; 2013 Oct; 64(4):654-63. PubMed ID: 23769588
[TBL] [Abstract][Full Text] [Related]
57. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
[TBL] [Abstract][Full Text] [Related]
58. Partial cystectomy during radical surgery for nonurological malignancy.
Weinstein RP; Grob BM; Pachter EM; Soloway S; Fair WR
J Urol; 2001 Jul; 166(1):79-81. PubMed ID: 11435828
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors for urachal cancer: a bayesian model-averaging approach.
Kim IK; Lee JY; Kwon JK; Park JJ; Cho KS; Ham WS; Hong SJ; Yang SC; Choi YD
Korean J Urol; 2014 Sep; 55(9):574-80. PubMed ID: 25237458
[TBL] [Abstract][Full Text] [Related]
60. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins HM; Skinner EC; Dorin RP; Ahmadi H; Djaladat H; Miranda G; Cai J; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):24.e13-9. PubMed ID: 23395238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
